Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PROTAC(H-PGDS)-4-TFC |
Target |
Mechanism H-PGDS inhibitors(hematopoietic prostaglandin D synthase inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H38N8O7 |
InChIKeyKQNXUQJGOJWQGL-UHFFFAOYSA-N |
CAS Registry- |